NCT00765375

Safety and Efficacy of the Use of Botox on Acne

Double-Blind, Randomized, Placebo-Controlled Study to Determine the Safety and the Efficacy of Using Botulinum Neurotoxin Type A Injections for Subjects With Mild to Moderate Acne Vulgaris

• Status: Terminated
• Phase: Phase 2
• Study type: Interventional
• Enrollment: 5 (actual)
• Sponsor: DeNova Research · Academic / Other
• Sex: All
• Age: 18 Years – 50 Years
• Healthy volunteers: Not accepted

Summary

• To determine the safety and efficacy of Botox Treatment in subjects with mild to moderate acne vulgaris defined by the Investigator's Global Assessment (IGA)

Detailed description

• 90 day trial, with botox being injected at baseline/screening visit. Photos will be taken throughout the study and patients will be evaluated by masked injector evaluator and a masked evaluator. Patient will complete a subject evaluation at each visit. Follow-up visits occur at Day 3, 7, 14, 30 and 90.

Conditions

• Acne Vulgaris

Interventions

Type	Name	Description
DRUG	Botulinum Neurotoxin Type A	1.5-3 units of Botox/lesion
DRUG	Bacteriostatic saline	.1 cc bacteriostatic saline/lesion

Timeline

• Start date: 2008-09-01
• Primary completion: 2008-12-01
• Completion: 2008-12-01
• First posted: 2008-10-02
• Last updated: 2018-06-29
• Results posted: 2015-04-30

Locations

1 site across 1 country: United States